首页> 外国专利> Controlled release methylphenidate compostions comprising at least two groups of particles, each with a methylphenidate core coated with a controlled release polymer coating, each group distinguished by the coating thickness

Controlled release methylphenidate compostions comprising at least two groups of particles, each with a methylphenidate core coated with a controlled release polymer coating, each group distinguished by the coating thickness

机译:控释哌醋甲酯组合物,包含至少两组颗粒,每组颗粒的哌醋甲酯芯均涂有控释聚合物涂层,每组的区别在于涂层厚度

摘要

Disclosed is a controlled release pharmaceutical composition comprising a plurality of particles for release control. The plurality of particles comprise a core material containing methylphenidate and a polymer coating layer for release control formed on the core material, wherein the plurality of particles for release control are identical in terms of the composition of the polymer in the polymer coating layer, but are divided into two or more groups based on the average thickness of the polymer coating layer for release control. The polymer of the polymer coating layer is a water-insoluble polymer, or a combination of the water-insoluble polymer and one or more selected from a group consisting of a water insoluble polymer, an enteric polymer and a gastric polymer. The particle groups for release control comprise a first particle group having an average coating layer thickness of 1 to 120 micron, and a second particle group having an average coating layer thickness of 10 to 250 micron.
机译:公开了一种控释药物组合物,其包含用于释放控制的多个颗粒。多个颗粒包括含有哌醋甲酯的芯材料和形成在芯材料上的用于控制释放的聚合物涂层,其中用于控制释放的多个颗粒就聚合物涂层中的聚合物组成而言是相同的,但是根据聚合物包衣层的平均厚度将其分为两组或更多组以控制释放。聚合物涂层的聚合物是水不溶性聚合物,或水不溶性聚合物与选自水不溶性聚合物,肠溶性聚合物和胃聚合物中的一种或多种的组合。用于释放控制的颗粒组包括平均涂层厚度为1至120微米的第一颗粒组和平均涂层厚度为10至250微米的第二颗粒组。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号